What dose of prednisolone should be used for allergy testing in a patient with suspected prednisolone allergy?

Prednisolone Allergy Testing Protocol

Critical First Principle: This is NOT About Treating Allergic Reactions

Allergy testing for suspected prednisolone hypersensitivity requires diagnostic skin testing with specific concentrations, NOT therapeutic dosing. The question asks about testing a patient who may be allergic to prednisolone itself—this is fundamentally different from using prednisolone to treat other allergic conditions.

Skin Testing Protocol for Suspected Corticosteroid Allergy

Initial Skin Prick Testing

• Begin with skin prick testing using a 10% prednisolone stock concentration as the initial screening method, reading results at 15-20 minutes with a positive result defined as a wheal ≥3 mm greater than the negative control 1
• Skin prick testing alone may miss true allergic reactions, as positive results can occur at either the prick or intradermal stages 1

Intradermal Testing (If Prick Test Negative)

• Proceed to intradermal testing using serial dilutions of 1:1000,1:100, and 1:10 if the skin prick test is negative but clinical suspicion remains high 1
• Intradermal testing is essential because patients with confirmed corticosteroid hypersensitivity (including those with anaphylaxis) may have negative prick tests but positive intradermal reactions 1, 2

Panel Testing for Cross-Reactivity

• Test a panel of corticosteroids including prednisolone, triamcinolone, methylprednisolone, hydrocortisone, and dexamethasone because cross-reactivity between different corticosteroids is well-documented 1, 3
• Cross-reactivity has been demonstrated between prednisolone and dexamethasone, as well as among multiple other corticosteroid preparations 4, 3

Interpretation and Limitations

Diagnostic Accuracy

• Skin testing provides sufficient evidence to diagnose allergy in patients with a clear history of immediate hypersensitivity (especially anaphylaxis), with 7 of 8 patients with anaphylaxis history showing positive skin tests in the largest case series 1
• Both false-positive and false-negative results occur: one patient had a positive skin test but negative oral challenge (false positive), and another had a negative skin test but positive oral challenge (false negative) 1

When Skin Testing is Insufficient

• Oral or parenteral challenge remains the only definitive method to demonstrate a safe alternative corticosteroid when skin testing results are equivocal or when confirming tolerance to an alternative agent 1, 2
• A combination of intradermal and patch testing is recommended when allergy to systemic corticosteroids is suspected, with provocation testing as the method of choice if skin tests remain negative 2

Clinical Context and Risk Factors

High-Risk Populations

• Allergic-type reactions to corticosteroids occur more frequently in asthmatic patients and renal transplant recipients, though the mechanism may not always represent true IgE-mediated allergy 5
• Patients with a history of corticosteroid-associated anaphylaxis have the highest likelihood of positive skin testing (87.5% in the largest series) 1

Reaction Patterns

• Immediate hypersensitivity reactions to corticosteroids occur with an estimated incidence of 0.1% 1
• Reactions can manifest as erythema, itching, flushing, hypotension, respiratory distress, or anaphylaxis occurring immediately to within 24 hours after administration 4, 2

Common Pitfalls to Avoid

• Do not rely solely on skin prick testing—intradermal testing is essential for adequate sensitivity 1, 2
• Do not test only the implicated corticosteroid—cross-reactivity necessitates panel testing to identify safe alternatives 1, 3
• Do not assume negative skin tests rule out allergy—false negatives occur, and challenge testing may be required 1, 2
• Do not confuse diagnostic testing doses with therapeutic doses—the concentrations used for allergy testing (10% stock for prick, 1:1000 to 1:10 for intradermal) are specifically for diagnosis, not treatment 1